These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16682936)

  • 1. The clinical utility of leptin therapy in metabolic dysfunction.
    Park JY; Gavrilova O; Gorden P
    Minerva Endocrinol; 2006 Jun; 31(2):125-31. PubMed ID: 16682936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical efficacy of the adipocyte-derived hormone leptin in metabolic dysfunction.
    Gorden P; Park JY
    Arch Physiol Biochem; 2006 Apr; 112(2):114-8. PubMed ID: 16931453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.
    Petersen KF; Oral EA; Dufour S; Befroy D; Ariyan C; Yu C; Cline GW; DePaoli AM; Taylor SI; Gorden P; Shulman GI
    J Clin Invest; 2002 May; 109(10):1345-50. PubMed ID: 12021250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin-replacement therapy for lipodystrophy.
    Oral EA; Simha V; Ruiz E; Andewelt A; Premkumar A; Snell P; Wagner AJ; DePaoli AM; Reitman ML; Taylor SI; Gorden P; Garg A
    N Engl J Med; 2002 Feb; 346(8):570-8. PubMed ID: 11856796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothalamic melanocortin signaling and leptin resistance--perspective of therapeutic application for obesity-diabetes syndrome.
    Masuzaki H; Tanaka T; Ebihara K; Hosoda K; Nakao K
    Peptides; 2009 Jul; 30(7):1383-6. PubMed ID: 19394382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy resistant diabetes mellitus and lipodystrophy: leptin therapy leads to improvement].
    Jazet IM; Jonker JT; Wijngaarden MA; Lamb H; Smelt AH
    Ned Tijdschr Geneeskd; 2013; 157(4):A5482. PubMed ID: 23343738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 20 years of leptin: leptin in common obesity and associated disorders of metabolism.
    DePaoli AM
    J Endocrinol; 2014 Oct; 223(1):T71-81. PubMed ID: 24973357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy.
    Lee JH; Chan JL; Sourlas E; Raptopoulos V; Mantzoros CS
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2605-11. PubMed ID: 16636130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long road to leptin.
    Friedman J
    J Clin Invest; 2016 Dec; 126(12):4727-4734. PubMed ID: 27906690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipokines in the HIV/HAART-associated lipodystrophy syndrome.
    Paruthi J; Gill N; Mantzoros CS
    Metabolism; 2013 Sep; 62(9):1199-205. PubMed ID: 23706880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical uses of leptin.
    Gorden P; Gavrilova O
    Curr Opin Pharmacol; 2003 Dec; 3(6):655-9. PubMed ID: 14644019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metreleptin for injection to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy.
    Meehan CA; Cochran E; Kassai A; Brown RJ; Gorden P
    Expert Rev Clin Pharmacol; 2016; 9(1):59-68. PubMed ID: 26465174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipodystrophies: adipose tissue disorders with severe metabolic implications.
    Cortés VA; Fernández-Galilea M
    J Physiol Biochem; 2015 Sep; 71(3):471-8. PubMed ID: 25833179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid regulation in lipodystrophy versus the obesity-associated metabolic syndrome: the dissociation of HDL-C and triglycerides.
    Joseph J; Shamburek RD; Cochran EK; Gorden P; Brown RJ
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1676-80. PubMed ID: 24926953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin in congenital and HIV-associated lipodystrophy.
    Tsoukas MA; Farr OM; Mantzoros CS
    Metabolism; 2015 Jan; 64(1):47-59. PubMed ID: 25267014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health risks of lipodystrophy and abdominal fat accumulation: therapeutic possibilities with leptin and human growth hormone.
    Van Gaal LF; Mertens IL; Abrams PJ
    Growth Horm IGF Res; 2003 Aug; 13 Suppl A():S4-9. PubMed ID: 12914718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function.
    Bruder-Nascimento T; Kress TC; Belin de Chantemele EJ
    F1000Res; 2019; 8():. PubMed ID: 31656583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin-replacement therapy in lipodystrophy.
    Mauvais-Jarvis F
    N Engl J Med; 2002 Jun; 346(25):2008; author reply 2009-10. PubMed ID: 12075066
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lipodystrophy. Mechanisms, clinical presentation, therapy].
    Miehle K; Stumvoll M; Fasshauer M
    Internist (Berl); 2011 Apr; 52(4):362, 364-6, 368-70 passim. PubMed ID: 21424143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin and adiponectin, but not IL18, are related with insulin resistance in treated HIV-1-infected patients with lipodystrophy.
    Veloso S; Escoté X; Ceperuelo-Mallafré V; López-Dupla M; Peraire J; Viladés C; Domingo P; Castro A; Olona M; Sirvent JJ; Leal M; Vendrell J; Richart C; Vidal F
    Cytokine; 2012 May; 58(2):253-60. PubMed ID: 22364914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.